Prilenia

1 follower


Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.

Industries

Headquarters

Employees

Links

Org chart

Michael R. Hayden

Collapse
Henk Schuring
Chief Regulatory & Commercialization Officer
Anne Sullivan
Chief Business Officer
Yael Cohen
SVP, Head of Clinical Operations
Elena Berelovich
SVP, Head of CMC
Michal Geva
SVP, Head of Research
Leehee Navon-Perry
Director, Medical Writing
Kelly Chen
Senior Director, Head of Biometrics
Andres Cruz-Herranz
Director of Clinical Development
Noga Gershoni-Emek
Scientific Affairs Manager
May Meltzer
Scientific IP Lead
Rob Lauzen
Chief Financial Officer